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137 Sleep disturbances in CF children: looking for severity predictors
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Sleep disorders are common in CF patients. Pediatric studies are contradictory.
Being aware of the incidence of respiratory sleep disturbance (RSD) and clinical
and respiratory function predictive factors is essential. We aimed to identify sleep
disturbances in CF children and determine associated spirometric indices as severity
predictors.
In-lab polysomnography (PSG) followed by spirometry was carried out in CF
children, 6 to 18 y. Baseline SpO2 was assessed. A questionnaire was applied.
Descriptive statistics and comparative tests were performed. Signiﬁcance level was
set at 5%.
Thirty-three subjects were included [16 males (48.5%); median age 12 y (6−18);
average BMI z-score −0.35 (dp 0.78)]. 29 patients (87.9%) had sleep quality and/or
RSD complaints. Sleep efﬁciency was reduced and sleep latency and wake after
sleep increased. N1, N2, N3, REM and awakenings were normal. The A/HI was
0.6/h (dp 0.9); mean RDI: 6.6 (dp 5.2). Mean wake SpO2 [97% (dp 1.1)] and sleep
SpO2 [95% (dp 2.7)] were normal; mean ODI was 2.36; minSpO2 was 89% (dp 4.1).
TcCO2 was normal. 51.5% of patients had nocturnal cough. There was a statistically
signiﬁcant difference between the waking and sleep SpO2 (r = 0.326, p = 0.064).
FEV1 was associated with sleep SpO2 (r = 0.528, p = 0.002). PSG data signiﬁ-
cantly correlate with the questionnaire for night awakenings and wake after sleep
(p = 0.985) and difﬁculty breathing during sleep and RDI (p = 0.722).
Most children had sleep complaints. The subjective assessment of sleep correlates
with PSG ﬁndings. These mild respiratory disease children had scarce nocturnal
SpO2 events, associated with disease severity assessed by spirometry. The associa-
tion between SpO2 awake and mean sleep SpO2 indicates a possible risk predictor
for nocturnal desaturation.
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Introduction: Chest radiography (CR) and computed tomography (CT) are com-
monly used for imaging of patients with cystic ﬁbrosis, and scoring is applied
to assess disease severity. Chest tomosynthesis (CTS) is a new imaging modality
providing better anatomic visualization than CR at radiation doses and costs lower
than CT.
Objective: To compare visibility and size of anatomic structures of relevance for
scoring in CTS and CT images.
Methods: 21 adult patients with cystic ﬁbrosis were examined both with CTS
(VolumeRAD; GE Healthcare) and volumetric CT (LightSpeed Pro 16, LightSpeed
VCT, Discovery CT750HD; GE healthcare and Somatom Deﬁnition, Siemens
Medical Solutions). The average effective dose for a standard patient was 0.13
and 4.5 mSv for CTS and CT, respectively. Comparison of visibility and manual
measurements of diameters of the central and peripheral bronchi and their accom-
panying artery, as well as bronchial wall thickness (BWT), were performed in a
non-blinded fashion.
Results: All central structures could be evaluated. Mean difference in diameter
of central bronchi, accompanying artery and BWT between CTS and CT was
−0.6 (SD 0.6), −0.7 (SD 0.7) and −0.4 (SD 0.2) mm, respectively. Peripheral
structures were more difﬁcult to assess by CTS. Peripheral bronchial diameter, BWT
and diameter of accompanying artery could be assessed by CTS in 20, 15 and 4
cases, respectively and mean difference between measurements was −0.5 (SD 0.5),
−0.3 (SD 0.3) and −0.4 (SD 0.4) mm, respectively.
Conclusion: This study indicates that peripheral structures are more difﬁcult
to evaluate by CTS and that CTS slightly underestimate size of structures in
comparison to CT.
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Objectives: X-ray and CT repetition during a CF patient life may become problem-
atic because of the cumulative radiation dose. Magnetic resonance imaging (MRI)
of the lungs might be a promising alternative to CT. However technical issues such
as the long acquisition times required by MRI compared to CT create challenges.
Long breath hold durations, needed to avoid motion corruption of the images, may
be difﬁcult to achieve for CF patients; resulting in limited diagnostic information.
We introduce a method to reconstruct image volumes for multiple phases of the
respiratory cycle using a single acquisition during free breathing.
Methods: A balanced Steady State Free Precession 3D radial sequence was
acquired in an interleaved fashion using ECG triggering to obtain diastolic cardiac
motion suppressed radial projections in k-space. The signal related to respiratory
motion was extracted from the ﬁrst projection, acquired along the superior-inferior
direction, of each interleave. Using this signal, the interleaves acquired during
user-selected phases of the respiratory cycle were identiﬁed and used for image
reconstruction. This sequence was tested in volunteers and in a CF patient and
compared with the breath hold 3D gradient echo sequence used in clinical routine.
Results: The new technique allowed visualization of the pulmonary vasculature
until a segmental level without contrast agent use. Rough parenchymal and bronchial
abnormalities were assessed as well as hypertrophied systemic arteries.
Conclusion: The free breathing sequence with its high isotropic spatial resolu-
tion (1.3mm3) and high intrinsic blood–parenchyma contrast shows promise for
examination of CF patients.
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Rationale: Chronic infection and inﬂammation plays a central role in CF lung
disease. Bronchoalveolar lavage (BAL) is considered the gold standard for deﬁning
airway microbiology in children. While many units routinely perform BAL in
children with CF, in our hospital it is done only when a child has surgery for
other reasons.
Objectives: To identify children who have undergone BAL and compare culture
results from BAL with cough swabs/sputum cultures.
Methods: Children were identiﬁed retrospectively, using surgical lists. Culture and
BAL results were checked using annual review summaries and pathology records.
Results: 20 children underwent BAL between 2011–2013; of these 19 had results
available. Mean time to culture results was 6 days for standard organisms however
Mycobacterium culture took signiﬁcantly longer. 6 children had new organisms
identiﬁed on BAL, however 4 of these were atypical bacteria of uncertain signif-
icance. 7 children grew organisms which had already been identiﬁed on cough
swabs, 6 had negative cultures. 2 children grew organisms on recent cough swabs
that were not grown from BAL.
Conclusions: BAL is a useful tool to help identify respiratory infection in children
with CF. It can identify organisms not picked up using non-invasive methods,
however false negative results are also possible. Some organisms cultured were
extremely rare and of questionable clinical signiﬁcance. The technique has several
limitations: it is invasive, costly, requires time and resources as well as risks
associated with general anaesthesia. Routine use when a child would not otherwise
be undergoing anaesthetic could not be justiﬁed based on our results.
